Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis

Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis

Abstract Background Treatment of latent tuberculosis infection (LTBI) in high-risk groups is an effective strategy for TB control and elimination in low incidence settings. A nine-month course of daily isoniazid (INH) has been the longest prescribed therapy; however, completion rates are suboptimal....

Full description

Bibliographic Details
Main Authors: Marie Nancy Séraphin, HsiaoChu Hsu, Helena J. Chapman, Joanne L. de Andrade Bezerra, Lori Johnston, Yang Yang, Michael Lauzardo
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Public Health
Subjects:
Latent tuberculosis infection
Prevention
Treatment outcomes
Online Access:http://link.springer.com/article/10.1186/s12889-019-7524-4

Similar Items

Similar Items